Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 173, 21-5

The Anti-Inflammatory CASPASE-12 Gene Does Not Influence SLE Phenotype in African-Americans

Affiliations

The Anti-Inflammatory CASPASE-12 Gene Does Not Influence SLE Phenotype in African-Americans

Trista Fuchs et al. Immunol Lett.

Abstract

In the vast majority of human populations, the gene encoding CASPASE-12 (CASP12) has a premature termination codon that precludes the production of protein. However, approximately 20% of persons of recent African descent have a single nucleotide polymorphism (#rs497116; A->G) that turns the stop codon into one encoding Arg. The subsequent functional allele is a risk factor for sepsis as it uniquely downregulates inflammatory cytokines in African-Americans (AA). To determine if CASP12 could be protective for systemic lupus erythematosus (SLE) in AA, we genotyped AA SLE patients and controls. There was a weak association between CASP12 genotype with the absence of anti-dsDNA autoantibodies in SLE patients. No effect was seen upon serum interleukin-1 beta levels, nor was any other protective effect noted for the CASP12 genotype, whether upon association with SLE, or any of the 11 American College of Rheumatology classification criteria. CASP12 genotype thus does not influence the phenotype of SLE in AA.

Keywords: Autoimmunity; CASPASE-12; Genetics; Inflammation; Interleukin-1; Lupus.

Similar articles

See all similar articles

Publication types

LinkOut - more resources

Feedback